These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8577023)

  • 1. Treatment of central venous catheter occlusions with ethanol and hydrochloric acid.
    Werlin SL; Lausten T; Jessen S; Toy L; Norton A; Dallman L; Bender J; Sabilan L; Rutkowski D
    JPEN J Parenter Enteral Nutr; 1995; 19(5):416-8. PubMed ID: 8577023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of central venous catheter occlusions with hydrochloric acid.
    Duffy LF; Kerzner B; Gebus V; Dice J
    J Pediatr; 1989 Jun; 114(6):1002-4. PubMed ID: 2498489
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of hydrochloric acid to clear obstructed central venous catheters.
    Shulman RJ; Reed T; Pitre D; Laine L
    JPEN J Parenter Enteral Nutr; 1988; 12(5):509-10. PubMed ID: 3184423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of superior vena cava syndrome with urokinase in an infant with a central venous catheter.
    Caglar MK; Tolboom J
    Helv Paediatr Acta; 1989 Jun; 43(5-6):483-6. PubMed ID: 2501237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing a protocol to prevent and treat pediatric central venous catheter occlusions.
    Harris JL; Maguire D
    J Intraven Nurs; 1999; 22(4):194-8. PubMed ID: 10476135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urokinase administration in pediatric patients with occluded central venous catheters.
    Wachs T
    J Intraven Nurs; 1990; 13(2):100-2. PubMed ID: 2313458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of obstruction and thrombosis due to central venous catheterization].
    Leititis JU
    Klin Padiatr; 1991; 203(6):420-3. PubMed ID: 1758144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of 6 years use of sodium hydroxide solution to clear partially occluded central venous catheters.
    Bader SG; Balke P; Jonkers-Schuitema CF; Tas TA; Sauerwein HP
    Clin Nutr; 2007 Feb; 26(1):141-4. PubMed ID: 17097197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of using L-cysteine as a catheter-clearing agent for nonthrombotic occlusions of central venous catheters in children.
    Pai VB; Plogsted S
    Nutr Clin Pract; 2014 Oct; 29(5):636-8. PubMed ID: 25118177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombosed central venous catheters: restoring function with 6-hour urokinase infusion after failure of bolus urokinase.
    Haire WD; Lieberman RP
    JPEN J Parenter Enteral Nutr; 1992; 16(2):129-32. PubMed ID: 1556806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant urokinase for restoration of patency in occluded central venous access devices. A double-blind, placebo-controlled trial.
    Haire WD; Deitcher SR; Mullane KM; Jaff MR; Firszt CM; Schulz GA; Schuerr DM; Schwartz LB; Mouginis TL; Barton RP
    Thromb Haemost; 2004 Sep; 92(3):575-82. PubMed ID: 15351854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous infusion of low-dose urokinase in the treatment of central venous catheter thrombosis in infants and children.
    Bagnall HA; Gomperts E; Atkinson JB
    Pediatrics; 1989 Jun; 83(6):963-6. PubMed ID: 2657625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of management for obstruction caused by precipitated medication or lipids in central venous access devices: A systematic review and meta-analysis.
    Zheng LY; Xue H; Yuan H; Liu SX; Zhang XY
    J Vasc Access; 2019 Nov; 20(6):583-591. PubMed ID: 30919720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complications and cost associated with parenteral nutrition delivered to hospitalized patients through either subclavian or peripherally-inserted central catheters.
    Cowl CT; Weinstock JV; Al-Jurf A; Ephgrave K; Murray JA; Dillon K
    Clin Nutr; 2000 Aug; 19(4):237-43. PubMed ID: 10952794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hickman catheter for long-term parenteral therapy. A prospective interdisciplinary study].
    Lang W; Schweiger H; Richter U; Richter R; Beck JD; Krasa M; Luthin D
    Med Klin (Munich); 1992 Aug; 87(8):412-7. PubMed ID: 1406473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of catheter occlusion in pediatric patients.
    Kerner JA; Garcia-Careaga MG; Fisher AA; Poole RL
    JPEN J Parenter Enteral Nutr; 2006; 30(1 Suppl):S73-81. PubMed ID: 16387916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyurethane central venous catheters, hydrochloric acid and 70% ethanol: a safety evaluation.
    McHugh GJ; Wild DJ; Havill JH
    Anaesth Intensive Care; 1997 Aug; 25(4):350-3. PubMed ID: 9288375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced need for replacement of long term parenteral nutrition catheters following endoluminal brushing.
    Allan PJ; McMahon M; Abraham A; Shaffer J; Teubner A; Lal S
    Clin Nutr; 2015 Feb; 34(1):146-50. PubMed ID: 24613144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigational use of tissue plasminogen activator (t-PA) for occluded central venous catheters.
    Atkinson JB; Bagnall HA; Gomperts E
    JPEN J Parenter Enteral Nutr; 1990; 14(3):310-1. PubMed ID: 2112648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Advantages of routine periodic replacement of the central endovenous catheter in total parenteral nutrition].
    González Avila G; Fajardo Rodríguez A
    Nutr Hosp; 1999; 14(2):67-70. PubMed ID: 10364783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.